Ageing Research Reviews · 2024 · 17 citations · 58 references
Life SciencesNeurobiologyNeuroscienceAgingCellular NeuroscienceGerontologyAlzheimer DiseaseBiological AgingCellular AgingCognitive AgingNeurodegenerative DiseasesNeurogenesisAge-related Brain ChangesAge-related DegenerationAge-related Neurodegenerative MechanismsAging-related PathologyAlzheimer Disease ProgressionHuman Embryonic Stem CellsNeural Stem Cell AgingOrganoids
Alzheimer's disease (AD) poses a complex challenge, with abnormal protein accumulation in the brain causing memory loss and cognitive decline. Traditional models fall short in AD research, prompting interest in 3D brain organoids (BOs) from human stem cells. These findings hold promise for unveiling the mechanisms of AD, especially in relation to aging. However, an understanding of the aging impact of AD remains elusive. BOs offer insight but face challenges. This review delves into the role of BOs in deciphering aging-related AD and acknowledges limitations. Strategies to enhance BOs for accurate aging modeling in AD brains are suggested. Strengthened by molecular advancements, BOs have the potential to uncover the aging phenotype, advancing AD research.
58
Cerebral organoids model human brain development and microcephaly
Madeline A. Lancaster, Magdalena Renner, Carol-Anne Martin et al. · Nature · 2013 · 5.4K citations · Full text
Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure
Xuyu Qian, Ha Nam Nguyen, Mingxi M. Song et al. · Cell · 2016 · 2.2K citations · Full text
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 2K citations · Full text
Medicine, Neurology, Pharmacology +17
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text
Medicine, Neurology, Neuroscience +14